Cargando...
Systemic administration of β(2)-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses
1. β(2)-Adrenoceptor agonists provide a potential therapy for muscle wasting and weakness, but their use may be limited by adverse effects on the heart, mediated in part, by β(1)-adrenoceptor activation. 2. Two β(2)-agonists, formoterol and salmeterol, are approved for treating asthma and have an ex...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2006
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1751341/ https://ncbi.nlm.nih.gov/pubmed/16432501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0706669 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|